• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CenterWatch Monthly May 2008 Issue

CenterWatch Monthly May 2008 Issue

May 14, 2008
CenterWatch Staff

Eli Lilly, Wyeth, Schering-Plough Rated Top Pharma Companies in Europe

Results of the CenterWatch 2008 Survey of Investigative Sites in Europe found Eli Lilly rated the top sponsor to work with. Also rated highly were Wyeth and Schering-Plough. The 2008 survey had more sites in Central and Eastern Europe reporting, and the survey was also extended to Canada. The number of countries reporting increased by 11 to 37. CenterWatch rated a total of 16 large pharmaceutical and biotech companies.

Cardiac Safety Services Back in Rhythm

Cardiac safety monitoring has developed into a sizable industry sector and the growing demand for these services has led to much activity in the space recently. Cardiac safety effects have become a common cause for drug withdrawals and delays in regulatory approval. Many concerns about serious cardiovascular side effects are related to drugs used for non-cardiac indications, such as the arthritis drug Vioxx.

European Biotech Outsourcing on Steep Learning Curve

Demand for contracted services in the European biotech sector is buoyant. As the industry matures and more biotech drug candidates reach clinical development, business opportunities for contract research organizations (CROs) and other service providers are growing.

Eye On: Muscular Dystrophy

There are nine known types of muscular dystrophy, which is a group of genetically based, degenerative diseases characterized by a progressive wasting and weakening of fibers of voluntary muscles. They are classified based on their pattern of inheritance, age of onset, and typical symptoms; together, they affect more than 110,000 people in the United States alone. In each of these forms, there is a defect in one of several proteins involved in linking the muscle fiber component F-actin to the sheath of tissue surrounding the muscle fiber.

To read the full articles for this issue or for more information on these and other breaking stories, please click here.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing